Nephron names Morgan Nichols Scarnecchia as Chief of Staff

Morgan Scarnecchia

Courtesy of Midlands Biz

Nephron Pharmaceuticals Corporation welcomed Morgan Nichols Scarnecchia as its Chief of Staff. In her new role, Scarnecchia will implement strategic business initiatives, manage daily operations and work alongside CEO, Lou Kennedy, in internal and external affairs.

“As two women who grew up in Lexington, Morgan and I not only share a great passion for the life sciences, but also South Carolina and the Midlands,” said Nephron CEO and Owner Lou Kennedy. “She is a great addition to our strong female leadership here at Nephron – and by working together, we will continue to drive Nephron forward.”

Before joining the Nephron team, Scarnecchia was the Director of Corporate Affairs for KOR Medical, where she built and managed the start-up’s key corporate accounts and communications for its various entities. Prior to that, she served first as an intern and later as Investor Relations Manager for SCbio.

Scarnecchia has served as Corporate Affairs and Investor Relations Manager at SCbio, where she was responsible for board and investor communications and leading life sciences workforce initiatives like the association’s K-12 education programs. She began her career at the biotechnology organization as its Membership and Marketing Coordinator, recruiting life science companies and implementing new stakeholder engagement strategies.

In 2019, Scarnecchia was crowned Miss South Carolina. During her reign, she traveled across South Carolina promoting Stronger With STEM, a personal initiative created to promote a 21st-century workforce in the areas of science, technology, engineering and mathematics.

Scarnecchia received a Bachelor of Science in Genetics from Clemson University and is currently pursuing her Master of Biotechnology and Business from Johns Hopkins University.

A West Columbia, S.C.-based company, Nephron develops and produces safe, affordable generic inhalation solutions and suspension products. The company also operates an industry-leading 503B Outsourcing Facility division which produces pre-filled sterile syringes, luer-lock vials, IV bottles and IV bags for hospitals across America, in an effort to alleviate drug shortage needs. For more information, please visit

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more